Executive Vice President, Finance and Chief Financial Officer · CONMED Corp (CNMD)

Todd Garner

A named executive officer of CONMED in every fiscal year CompBrief holds from FY2023 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$3,297,396

FY2024: $4,642,713

Compensation figures as of the proxy filed April 7, 2026 (DEF 14A).

Todd Garner compensation by year

CONMED Summary Compensation Table · all 3 fiscal years held
In US dollars, as CONMED reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024FY2025
Salary$538,971$565,776$610,000
Bonus—$0$0
Stock awards$425,064$2,099,933$500,096
Option awards$1,274,951$1,499,807$1,499,990
Non-equity incentive$579,057$397,860$659,354
Pension and deferred compensation—$0$0
All other$53,821$79,337$27,956
Total$2,871,864$4,642,713$3,297,396

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CONMED Corp DEF 14A filed April 7, 2026, accession 0000816956-26-000047, and prior-year filings. Open the filing on EDGAR.

$2.9M
$4.6M
$3.3M
FY23
FY24
FY25
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU15,227$618,216—
RSU2,870$116,522—
RSU1,403$56,962—
RSU487$19,772—
Option22,000—$144.55
Option9,010—$122.55
Option19,328—$96.16
Option35,742—$79.95
Option61,475—$58.33

Per the Outstanding Equity Awards at Fiscal Year-End table in CONMED Corp's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

CONMED’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Patrick BeyerPresident and Chief Executive Officer$7,634,873
Todd Garner · this pageExecutive Vice President, Finance and Chief Financial Officer$3,297,396
Hollie FoustExecutive Vice President, General Counsel and Corporate Secretary$1,842,776
Brent LalomiaExecutive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs, and Commercial Operations$1,662,776
Peter ShagoryExecutive Vice President, Strategy and Corporate Development$1,563,789

The full CONMED compensation record

free company brief

This page is one person within CONMED's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order CONMED's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CONMED's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy